KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Equity Average (2018 - 2025)

Novartis Ag's Equity Average history spans 8 years, with the latest figure at $45.3 billion for Q4 2025.

  • For Q4 2025, Equity Average changed 0.22% year-over-year to $45.3 billion; the TTM value through Dec 2025 reached $45.3 billion, changed 0.22%, while the annual FY2025 figure was $45.3 billion, 0.22% changed from the prior year.
  • Equity Average for Q4 2025 was $45.3 billion at Novartis Ag, roughly flat from $45.4 billion in the prior quarter.
  • Across five years, Equity Average topped out at $63.6 billion in Q4 2022 and bottomed at $33.9 billion in Q4 2021.
  • The 5-year median for Equity Average is $45.4 billion (2024), against an average of $48.3 billion.
  • The largest annual shift saw Equity Average surged 1538.83% in 2021 before it dropped 16.56% in 2023.
  • A 5-year view of Equity Average shows it stood at $33.9 billion in 2021, then skyrocketed by 87.76% to $63.6 billion in 2022, then decreased by 16.56% to $53.1 billion in 2023, then dropped by 14.48% to $45.4 billion in 2024, then decreased by 0.22% to $45.3 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Equity Average are $45.3 billion (Q4 2025), $45.4 billion (Q4 2024), and $53.1 billion (Q4 2023).